 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| W61922 | 3-[3-(3-aminobenzyl)-4-oxo-1,4-dihydropyridazin-1-(4H)-one]benzonitrile | 1314392-84-1 | 95% |
| W61923 | 5-(methoxymethyl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrimidine | 1314390-09-4 | 95% |
| W61924 | 3-(2-methoxyethoxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoline | 1314390-51-6 | 95% |
| W61925 | 3-(chloromethyl)-1-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-4-yl)pyridazin-4(2H)-one | 1314389-77-9 | 95% |
| W61926 | 3-[(2-methyl-2H-imidazol-5-yl)methyl]-1-(1-methyl-1H-pyrazol-4-yl)pyridazin-4(1H)-one | 1314381-06-0 | 95% |
| W61927 | methyl 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-thiazole-5-carboxylate | 1314390-02-7 | 95% |
| W61928 | 1-(1-methyl-1H-pyrazol-4-yl)-3-[3-(1,3-thiazol-2-yl)benzyl]pyridazin-4(1H)-one | 1314380-77-2 | 95% |
| W61929 | 3-(hydroxymethyl)-1-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-4-yl)pyridazin-4(2H)-one | 1314389-81-5 | 95% |
| W61930 | methyl 4-oxo-1-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-4-yl)-1,4-dihydropyridazine-3-carboxylate | 1314389-78-0 | 95% |
| W61931 | 1-butyl-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-1,2,4-triazole | 1314390-74-3 | 95% |
| W61932 | 5-(ethoxymethyl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrimidine | 1314390-16-3 | 95% |
| W61933 | 5-(2,5-dihydrofuran-2-yl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrimidine | 1314391-72-4 | 95% |
| W61934 | 5-ethoxy-4-methyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrimidine | 1314391-35-9 | 95% |
| W61935 | 1-(3-methoxypropyl)-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-1,2,4-triazole | 1314390-76-5 | 95% |
| W61936 | 1-(3-methylbutyl)-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-1,2,4-triazole | 1314390-78-7 | 95% |
| W61937 | 2-{2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrimidin-5-yl}propan-2-ol | 1314390-07-2 | 95% |
| W61938 | 1-(4-chlorophenyl)-3-(quinolin-6-ylmethyl)pyridazin-4(1H)-one | 1314381-00-4 | 95% |
| W61939 | 1-(1-methyl-1H-pyrazol-4-yl)-3-[(2-methylquinolin-5-yl)methyl]pyridazin-4(1H)-one | 1314381-01-5 | 95% |
| W61940 | 5-(1-methoxy-1-methylethyl)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrimidine | 1314390-23-2 | 95% |
| W61941 | 1-(1-methyl-1H-pyrazol-4-yl)-3-[3-(pyrazin-2-yl)benzyl]pyridazin-4(1H)-one | 1314380-95-4 | 95% |
| W61942 | 1-(1-methyl-1H-pyrazol-4-yl)-3-[3-(1-methyl-1H-pyrazol-3-yl)benzyl]pyridazin-4(1H)-one | 1314380-96-5 | 95% |
| W61943 | 1-(1-methyl-1H-pyrazol-4-yl)-3-[3-(2-methyl-2H-tetrazol-5-yl)benzyl]pyridazin-4(1H)-one | 1314381-15-1 | 95% |
| W61944 | 2-(3-{[1-(1-methyl-1H-pyrazol-4-yl)-4-oxo-1,4-dihydropyridazin-3-yl]methyl}phenyl)acetamide | 1314381-05-9 | 95% |
| W61945 | 3-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzyl]-1-(1-methyl-1H-pyrazol-4-yl)pyridazin-4(1H)-one | 1314380-99-8 | 95% |
| W61946 | 5-{[1-(1-methyl-1H-pyrazol-4-yl)-4-oxo-1,4-dihydropyridazin-3-yl]methyl}-1,3-benzoxazol-2(3H)-one | 1314380-81-8 | 95% |
| W61947 | 3-(3-bromophenyl)-5-propyl-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-1,2,4-triazole | 1314390-93-6 | 95% |
| W61948 | 4-oxo-1-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-4-yl)-1,4-dihydropyridazine-3-carboxylic acid | 1314389-79-1 | 95% |
| W61949 | 5-ethoxy-2-[2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrimidine | 1314391-12-2 | 95% |
| W61950 | 2-(3-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yloxy)pyrimidine | 1314391-28-0 | 95% |
| W61951 | 5-(2-methoxyethoxy)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrimidine | 1314391-00-8 | 95% |
|
|
|
|
